Related Experiment Video
Updated: Jul 16, 2025

Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
Rapid Detection of blaKPC in Carbapenem-Resistant Enterobacterales Based on CRISPR/Cas13a
Mingjun Liang1, Bin Xiao2, Lidan Chen1
1Department of Laboratory Medicine, General Hospital of Southern Theater Command, No. 111, Liuhua Road, Yuexiu District, Guangzhou City, 510010, Guangdong Province, China.
Abstract:
Klebsiella pneumoniae carbapenemase (KPC) is a crucial enzyme that causes carbapenem resistance in Enterobacterales, and infections by these "superbugs" are extremely challenging to treat. Therefore, there is a pressing need for a rapid and accurate KPC detection test to control the prevalence of carbapenem-resistant Enterobacterales (CREs). In this study, we established a novel method for detection of blaKPC, the gene responsible for encoding KPC, based on a recombinase polymerase amplification (RPA) and a CRISPR/Cas13a reaction coupled to fluorophore activation (termed RPA-Cas13a assay). We carefully selected a pair of optimal amplification primers for blaKPC and achieved a lower limit of detection of approximately 2.5 copies/μL by repeatedly amplifying a recombinant plasmid containing blaKPC. The RPA-Cas13a assay demonstrated a sensitivity of 96.5% and specificity of 100% when tested on 57 blaKPC-positive CRE strains, which were confirmed by DNA sequencing. Moreover, in 311 sputum samples, the theoretical antibiotic resistance characteristics of blaKPC-positive strains obtained by the RPA-Cas13a assay were highly consistent with the results of antibiotic susceptibility test (Kappa = 0.978 > 0.81, P < 0.01). In conclusion, the RPA-Cas13a system is a simple and one-hour efficient technology for the detection of a potentially fatal antibiotic resistance gene.
Insights
A new RPA-Cas13a assay rapidly detects the blaKPC gene, crucial for carbapenem resistance in Enterobacterales. This simple, one-hour test aids in controlling challenging superbug infections.
Area of Science:
- Molecular Biology
- Antimicrobial Resistance
- Diagnostic Development
Background:
- Klebsiella pneumoniae carbapenemase (KPC) is a key enzyme driving carbapenem resistance in Enterobacterales.
- Infections caused by carbapenem-resistant Enterobacterales (CREs) pose significant treatment challenges.
- Rapid and accurate KPC detection is essential for controlling CRE prevalence.
Purpose of the Study:
- To develop a novel, rapid, and accurate method for detecting the blaKPC gene.
- To establish a recombinase polymerase amplification (RPA) and CRISPR/Cas13a-based assay for KPC detection.
Main Methods:
- Developed a blaKPC detection assay using recombinase polymerase amplification (RPA) and CRISPR/Cas13a with fluorophore activation (RPA-Cas13a).
- Optimized amplification primers for blaKPC and determined the lower limit of detection using recombinant plasmids.
- Validated the assay on 57 blaKPC-positive CRE strains and 311 sputum samples.
Main Results:
- Achieved a lower limit of detection of approximately 2.5 copies/μL for the blaKPC gene.
- The RPA-Cas13a assay demonstrated 96.5% sensitivity and 100% specificity against DNA sequencing.
- Results from 311 sputum samples showed high consistency (Kappa = 0.978) between the assay and antibiotic susceptibility testing.
Conclusions:
- The RPA-Cas13a system offers a simple, efficient, one-hour method for detecting the blaKPC gene.
- This technology can aid in the rapid identification of potentially fatal antibiotic resistance genes.
- The assay shows promise for controlling the spread of carbapenem-resistant superbugs.
More Related Videos
09:03Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
Published on: December 23, 2022
10:16Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
Published on: August 16, 2024
Related Concept Videos
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR/Cas9 Genome Editing
The Antiviral System of Bacteria and Archaea: CRISPR